XRF Scientific Yönetim

Yönetim kriter kontrolleri 4/4

XRF Scientific CEO'su Vance Stazzonelli, Jun2008 tarihinde atandı, in görev süresi 16.42 yıldır. in toplam yıllık tazminatı A$ 722.31K olup, şirket hissesi ve opsiyonları dahil olmak üzere 57% maaş ve 43% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.6% ine doğrudan sahiptir ve bu hisseler A$ 1.41M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 11.3 yıl ve 12.5 yıldır.

Anahtar bilgiler

Vance Stazzonelli

İcra Kurulu Başkanı

AU$722.3k

Toplam tazminat

CEO maaş yüzdesi	57.0%
CEO görev süresi	16.4yrs
CEO sahipliği	0.6%
Yönetim ortalama görev süresi	11.3yrs
Yönetim Kurulu ortalama görev süresi	12.5yrs

Son yönetim güncellemeleri

Recent updates

Here's Why XRF Scientific (ASX:XRF) Can Manage Its Debt Responsibly

Nov 13

Analysts Have Made A Financial Statement On XRF Scientific Limited's (ASX:XRF) Annual Report

Aug 21

Why The 22% Return On Capital At XRF Scientific (ASX:XRF) Should Have Your Attention

Oct 05

XRF Scientific (ASX:XRF) Is Increasing Its Dividend To A$0.033

Sep 19

XRF Scientific's (ASX:XRF) Upcoming Dividend Will Be Larger Than Last Year's

Aug 28

Do XRF Scientific's (ASX:XRF) Earnings Warrant Your Attention?

Aug 22

Does XRF Scientific (ASX:XRF) Deserve A Spot On Your Watchlist?

Feb 01

XRF Scientific (ASX:XRF) Seems To Use Debt Rather Sparingly

Oct 19

We Think XRF Scientific (ASX:XRF) Can Manage Its Debt With Ease

May 12

XRF Scientific (ASX:XRF) Shareholders Will Want The ROCE Trajectory To Continue

Apr 21

Is Now The Time To Put XRF Scientific (ASX:XRF) On Your Watchlist?

Oct 01

XRF Scientific (ASX:XRF) Is Looking To Continue Growing Its Returns On Capital

May 18

Does XRF Scientific (ASX:XRF) Have A Healthy Balance Sheet?

Apr 19

An Intrinsic Calculation For XRF Scientific Limited (ASX:XRF) Suggests It's 23% Undervalued

Mar 17

XRF Scientific (ASX:XRF) Strong Profits May Be Masking Some Underlying Issues

Mar 01

Is Now The Time To Put XRF Scientific (ASX:XRF) On Your Watchlist?

Feb 17

Our View On XRF Scientific's (ASX:XRF) CEO Pay

Jan 27

Who Has Been Selling XRF Scientific Limited (ASX:XRF) Shares?

Jan 12

XRF Scientific Limited's (ASX:XRF) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Dec 23

XRF Scientific Limited's (ASX:XRF) Intrinsic Value Is Potentially 22% Below Its Share Price

Dec 10

The Returns At XRF Scientific (ASX:XRF) Provide Us With Signs Of What's To Come

Nov 25

CEO Tazminat Analizi

Vance Stazzonelli'un ücretlendirmesi XRF Scientific'un kazancına kıyasla nasıl değişti?
Tarih	Toplam Tazminat	Maaş	Şirket Kazançları
Jun 30 2024	AU$722k	AU$412k	AU$9m
Mar 31 2024	n/a	n/a	AU$9m
Dec 31 2023	n/a	n/a	AU$8m
Sep 30 2023	n/a	n/a	AU$8m
Jun 30 2023	AU$774k	AU$362k	AU$8m
Mar 31 2023	n/a	n/a	AU$7m
Dec 31 2022	n/a	n/a	AU$7m
Sep 30 2022	n/a	n/a	AU$7m
Jun 30 2022	AU$409k	AU$292k	AU$6m
Mar 31 2022	n/a	n/a	AU$6m
Dec 31 2021	n/a	n/a	AU$6m
Sep 30 2021	n/a	n/a	AU$5m
Jun 30 2021	AU$365k	AU$278k	AU$5m
Mar 31 2021	n/a	n/a	AU$5m
Dec 31 2020	n/a	n/a	AU$4m
Sep 30 2020	n/a	n/a	AU$3m
Jun 30 2020	AU$337k	AU$271k	AU$3m
Mar 31 2020	n/a	n/a	AU$3m
Dec 31 2019	n/a	n/a	AU$3m
Sep 30 2019	n/a	n/a	AU$2m
Jun 30 2019	AU$336k	AU$270k	AU$2m
Mar 31 2019	n/a	n/a	AU$2m
Dec 31 2018	n/a	n/a	AU$2m
Sep 30 2018	n/a	n/a	AU$1m
Jun 30 2018	AU$292k	AU$262k	AU$1m

Tazminat ve Piyasa: Vance 'nin toplam tazminatı ($USD 469.40K ), Australian pazarındaki benzer büyüklükteki şirketler için ortalamanın altındadır ($USD 706.54K ).

Tazminat ve Kazançlar: Vance 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.

CEO

Vance Stazzonelli

16.4yrs

Görev süresi

AU$722,314

Tazminat

Mr. Vance Stazzonelli, B.Comm has been the Chief Executive Officer of XRF Scientific Limited since August 6, 2012 and Company Secretary since June 16, 2008. Mr. Stazzonelli has been Managing Director and D...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Vance Stazzonelli	MD, Company Secretary & Director	16.4yrs	AU$722.31k	0.60% A$ 1.4m
Andrew Watson	CFO & Joint Company Secretary	11.3yrs	AU$470.25k	0.054% A$ 127.2k
Stephen Prossor	Business Development Manager	10.3yrs	AU$152.54k	1.9% A$ 4.5m

11.3yrs

Ortalama Görev Süresi

Deneyimli Yönetim: XRF 'un yönetim ekibi deneyimli ve deneyimlidir ( 11.3 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Vance Stazzonelli	MD, Company Secretary & Director	6.8yrs	AU$722.31k	0.60% A$ 1.4m
Frederick Grimwade	Independent Non-Executive Chairman	12.5yrs	AU$111.67k	0.39% A$ 924.1k
David Kiggins	Non-Executive Independent Director	12.5yrs	AU$77.23k	0.15% A$ 360.5k
David Brown	Non-Executive Director	20.4yrs	AU$302.58k	6.55% A$ 15.4m

12.5yrs

Ortalama Görev Süresi

66yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: XRF 'in yönetim kurulu deneyimli ve tecrübelidir (ortalama görev süresi 12.5 yıldır).

XRF Scientific Yönetim

Yönetim kriter kontrolleri 4/4

Anahtar bilgiler

Son yönetim güncellemeleri

XRF Scientific Limited, Annual General Meeting, Oct 21, 2024

XRF Scientific Limited, Annual General Meeting, Oct 31, 2023

Non-Executive Director recently bought AU$89k worth of stock

Non-Executive Director recently bought AU$61k worth of stock

Insufficient new directors

XRF Scientific Limited, Annual General Meeting, Oct 21, 2022

Recent updates

XRF Scientific Limited (ASX:XRF) agreed to acquire Labfit Pty Ltd for AUD 1.5 million.

Here's Why XRF Scientific (ASX:XRF) Can Manage Its Debt Responsibly

Now 20% undervalued

Price target increased by 8.0% to AU$1.75

XRF Scientific Limited, Annual General Meeting, Oct 21, 2024

Upcoming dividend of AU$0.039 per share

XRF Scientific Limited Announces Ordinary Full Franked Dividend for the Twelve Months Ended June 30, 2024, Payment Date of September 27, 2024

Analysts Have Made A Financial Statement On XRF Scientific Limited's (ASX:XRF) Annual Report

Full year 2024 earnings: EPS and revenues exceed analyst expectations

XRF Scientific Limited (ASX:XRF) completed the acquisition of remaining 50% stake in Orbis Mining Pty. Ltd. for AUD 3.8 million.

Now 22% undervalued

Price target increased by 19% to AU$1.55

XRF Scientific Limited to Report Fiscal Year 2024 Results on Aug 20, 2024

Now 24% undervalued

Now 24% undervalued

Now 24% undervalued

Now 24% undervalued

Now 24% undervalued

Now 25% undervalued

Now 23% undervalued

Now 23% undervalued

Now 22% undervalued

Now 20% undervalued

XRF Scientific (ASX:XRF) Seems To Use Debt Rather Sparingly

Now 21% undervalued

First half 2024 earnings released: EPS: AU$0.033 (vs AU$0.028 in 1H 2023)

Is Now The Time To Look At Buying XRF Scientific Limited (ASX:XRF)?

Returns On Capital Are A Standout For XRF Scientific (ASX:XRF)

New minor risk - Market cap size

Investor sentiment improves as stock rises 15%

Now 22% undervalued after recent price drop

Why The 22% Return On Capital At XRF Scientific (ASX:XRF) Should Have Your Attention

XRF Scientific Limited, Annual General Meeting, Oct 31, 2023

Upcoming dividend of AU$0.033 per share at 3.0% yield

XRF Scientific (ASX:XRF) Is Increasing Its Dividend To A$0.033

XRF Scientific's (ASX:XRF) Upcoming Dividend Will Be Larger Than Last Year's

New minor risk - Dividend sustainability

Full year 2023 earnings: EPS and revenues miss analyst expectations

Do XRF Scientific's (ASX:XRF) Earnings Warrant Your Attention?

XRF Scientific Limited Announces Ordinary Fully Paid Dividend for the Twelve Months Ended June 30, 2023, Payment Date of October 13, 2023

Non-Executive Director recently bought AU$89k worth of stock

New minor risk - Market cap size

Investor sentiment improves as stock rises 19%

Non-Executive Director recently bought AU$61k worth of stock

Investor sentiment improves as stock rises 18%

Now 23% undervalued

First half 2023 earnings released: EPS: AU$0.028 (vs AU$0.021 in 1H 2022)

Does XRF Scientific (ASX:XRF) Deserve A Spot On Your Watchlist?

Insufficient new directors

Now 21% undervalued

XRF Scientific (ASX:XRF) Seems To Use Debt Rather Sparingly

XRF Scientific Limited Announces Dividend That Relates to the Financial Reporting or Payment Period Ended on June 30, 2022, Payable on October 14, 2022

Upcoming dividend of AU$0.025 per share

XRF Scientific Limited, Annual General Meeting, Oct 21, 2022

Full year 2022 earnings released: EPS: AU$0.045 (vs AU$0.038 in FY 2021)

XRF Scientific Limited Announces Fully Franked Ordinary Dividend for the Year Ended June 30, 2022, Payable on 14 October 2022

Now 20% undervalued

We Think XRF Scientific (ASX:XRF) Can Manage Its Debt With Ease

Now 24% undervalued

Price target increased to AU$0.65

Insufficient new directors

XRF Scientific (ASX:XRF) Shareholders Will Want The ROCE Trajectory To Continue

First half 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Insufficient new directors

Is Now The Time To Put XRF Scientific (ASX:XRF) On Your Watchlist?

Upcoming dividend of AU$0.02 per share

Full year 2021 earnings released: EPS AU$0.038 (vs AU$0.023 in FY 2020)

Price target increased to AU$0.46

Non-Executive Director recently bought AU$72k worth of stock